Your session is about to expire
← Back to Search
Recovery Enhancement Program for Living Organ Donors
N/A
Waitlist Available
Led By Guiliano Testa, MD
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages ≥ 18 years
Approved for evaluation to be a living liver or kidney donor
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from post-transplant discharge to 1 year follow-up
Awards & highlights
Study Summary
This trial will test if using certain resources before a transplant can help the patient recover better and faster after the transplant.
Who is the study for?
This trial is for adults over 18 who are approved to be evaluated as living liver or kidney donors. They must be cleared by a doctor to exercise, willing to follow the study's rules including an exercise plan and visits, and not have any health issues that prevent walking alone. Pregnant or breastfeeding individuals cannot participate.Check my eligibility
What is being tested?
The study is testing a Recovery Enhancement Program designed specifically for living organ donors. It aims to see if using pre-transplant resources helps achieve better and quicker recovery after donating an organ.See study design
What are the potential side effects?
Since this program involves an exercise regimen tailored for potential living donors, side effects might include typical risks associated with physical activity such as muscle soreness or strain but will vary based on individual health status.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I am approved to be a living liver or kidney donor.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from post-transplant discharge to 1 year follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from post-transplant discharge to 1 year follow-up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Duration in ICU
Duration to return of daily activities
Incidence of Post-operative hospital re-admissions
+3 moreTrial Design
3Treatment groups
Active Control
Group I: Living Liver donorActive Control1 Intervention
Recovery enhancement program:
At least 6 weeks of physical and relaxation skills training pre-transplant.
Taking nutritional drink for 5 days before and after the surgery.
Opioid sparing pain management.
Group II: Living Kidney donor (Control)Active Control1 Intervention
Subjects maintain the same lifestyle without practicing physical training, relaxation skills or nutritional drink before and after the surgery.
To control post-op pain, subject will use medication per standard of care, including PCA pump.
Group III: Living Kidney donorActive Control1 Intervention
Recovery Enhancement Program
At least 4 weeks of physical and relaxation skills training pre-transplant.
Taking nutritional drink for 5 days before and after the surgery.
Opioid sparing pain management.
Find a Location
Who is running the clinical trial?
Baylor Research InstituteLead Sponsor
200 Previous Clinical Trials
203,361 Total Patients Enrolled
Guiliano Testa, MDPrincipal InvestigatorSimmons Transplant Institute, Baylor University Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am approved to be a living liver or kidney donor.You are pregnant or currently breastfeeding.I cannot walk by myself due to a health condition.
Research Study Groups:
This trial has the following groups:- Group 1: Living Liver donor
- Group 2: Living Kidney donor (Control)
- Group 3: Living Kidney donor
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment presently open for this trial?
"According to clinicaltrials.gov, the study is not accepting any new candidates at present. This medical trial was made available on April 20th 2017 and last updated July 19th 2022; however, there are other active trials that require volunteers."
Answered by AI
Share this study with friends
Copy Link
Messenger